Diversity in Clinical Trials

MHP and RPM to democratize access to trials and increase diversity access for clinical trials and care.

Moderator: Taren Grom



  • Tami Klerr, Executive VP and Chief Business Development & Marketing Officer, PRA Health Sciences, 2012 PharmaVOICE 100

  • Kent Thoelke, Executive Vice President and Chief Scientific Officer, PRA Health Sciences, 2013 PharmaVOICE 100

  • Elizabeth Garner, MD, Chief Medical Officer, ObsEva, 2019 PharmaVOICE 100

  • Jessica Scott, MD, JD, Head of R&D Patient Engagement Office, Takeda Pharmaceutical Company, 2020 PharmaVOICE 100